Detalhe da pesquisa
1.
Regulatory authority and clinical acceptability: Physicians' responses to regulatory drug safety warnings.
Br J Clin Pharmacol
; 88(2): 713-722, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34337777
2.
Media coverage of drug regulatory agencies' safety advisories: A case study of citalopram and denosumab.
Br J Clin Pharmacol
; 86(7): 1416-1429, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32067255
3.
Perspectives on how to build bridges between regulation, health technology assessment and clinical guideline development: a qualitative focus group study with European experts.
BMJ Open
; 13(8): e072309, 2023 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37640462
4.
Regulating patient access to therapeutics in Denmark: a rhetorical analysis of welfare imaginaries in public controversy.
J Law Biosci
; 8(2): lsaa047, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34408897
5.
Why do general practitioners disregard direct to healthcare professional communication? A user-oriented evaluation to improve drug safety communication.
Basic Clin Pharmacol Toxicol
; 128(3): 463-471, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33043558
6.
Preparation of Direct Healthcare Professional Communication: An Exploratory Study on the Experiences and Perceptions of European Pharmaceutical Companies and the EMA.
Ther Innov Regul Sci
; 54(3): 631-639, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33301149
7.
Preparation of Direct Healthcare Professional Communication: An Exploratory Study on the Experiences and Perceptions of European Pharmaceutical Companies and the EMA.
Ther Innov Regul Sci
; : 2168479019871041, 2019 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31510799
8.
The effectiveness of direct to healthcare professional communication - A systematic review of communication factor studies.
Res Social Adm Pharm
; 15(5): 475-482, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31130181